Turn Therapeutics Inc. Common Stock Cash Flow Conversion Efficiency
Turn Therapeutics Inc. Common Stock cash flow conversion efficiency. Based on the latest financial reports, Turn Therapeutics Inc. Common Stock (TTRX) has a cash flow conversion efficiency ratio of -1.344x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-923.36K) by net assets ($686.89K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Turn Therapeutics Inc. Common Stock (2023–2025)
Cash flow conversion efficiency of Turn Therapeutics Inc. Common Stock from 2023 to 2025. This chart illustrates how Turn Therapeutics Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. View TTRX live share price for real-time trading data and today's change.
Turn Therapeutics Inc. Common Stock Cash Flow Conversion Ratio Explained
Turn Therapeutics Inc. Common Stock cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Turn Therapeutics Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Turn Therapeutics Inc. Common Stock ranked by their cash flow conversion efficiency. Also see Turn Therapeutics Inc. Common Stock (TTRX) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BLS E-Services Limited
NSE:BLSE
|
0.018x |
|
Nanjing Chixia Development Co Ltd
SHG:600533
|
0.003x |
|
Clearview Wealth Ltd
AU:CVW
|
-3.782x |
|
Panin Financial Tbk
JK:PNLF
|
0.014x |
|
Jiangsu Holly Corp
SHG:600128
|
0.038x |
|
Plum Acquisition Corp. IV Unit
NASDAQ:PLMKU
|
-0.001x |
|
Holcim Argentina SA
BA:HARG
|
-0.102x |
|
Picpay Holdings Netherlands N.V. Class A Common Shares
NASDAQ:PICS
|
0.736x |
Annual Cash Flow Conversion Efficiency for Turn Therapeutics Inc. Common Stock (2023–2025)
The table below shows the annual cash flow conversion efficiency of Turn Therapeutics Inc. Common Stock from 2023 to 2025. Review Turn Therapeutics Inc. Common Stock (TTRX) flexibility index to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $4.69 Million | $-2.56 Million | -0.547x | -107.13% |
| 2024-12-31 | $-177.43K | $-1.36 Million | 7.672x | +147.76% |
| 2023-12-31 | $85.77K | $-1.38 Million | -16.063x | -- |
About Turn Therapeutics Inc. Common Stock
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and de… Read more